Last updated: February 20, 2026
Who are the primary manufacturers of PROVOCHOLINE?
PROVOCHOLINE (acetylcholine chloride) is a cholinergic agent used primarily in ophthalmology and for testing autonomic nerve function. It is produced by several pharmaceutical companies, often as a generic product.
Major Suppliers and Manufacturers
| Manufacturer Name |
Country of Origin |
Notable Details |
| Akorn, Inc. |
United States |
Offers preservative-free formulations, marketed in the US. |
| Sandoz (Novartis) |
Switzerland |
Supplies branded and generic forms, globally distributed. |
| JGL (Jalomed Pharma) |
India |
Provides generic versions for regional markets. |
| Hisamitsu Pharmaceutical Co. |
Japan |
Manufactures acetylcholine for specific markets. |
| Remedica Ltd. |
Cyprus |
Specializes in generic injectables and solutions. |
Additional Notable Suppliers
- LG Life Sciences (South Korea): Produces various ophthalmic agents including acetylcholine chloride.
- pHarma (Switzerland): Offers compounded versions of acetylcholine for research and clinical use.
Regulatory and Market Status
- US Market: Available via multiple suppliers, primarily as generic formulations. Follows FDA regulations for manufacturing and distribution.
- European Market: Listed under the European Pharmacopoeia, with distribution through authorized generic and branded suppliers.
- Asian Market: Widely available from regional pharmaceutical companies, especially India, South Korea, and Japan.
Supply Chain Considerations
Most suppliers obtain bulk synthetic acetylcholine chloride through chemical intermediates produced in specialized chemical manufacturing plants. These intermediates are then formulated into ophthalmic solutions or injectable forms in compliance with Good Manufacturing Practice (GMP) standards.
Key Points:
- Many suppliers are located in North America, Europe, and Asia.
- The product quality, formulation, and packaging standards vary depending on the supplier.
- Supply disruptions can occur due to raw material shortages, regulatory changes, or manufacturing issues.
- Contract manufacturing organizations (CMOs) also produce and supply acetylcholine chloride for various brands.
Market Dynamics
- The demand for PROVOCHOLINE remains steady in ophthalmology and testing contexts.
- The generic drug market for cholinergic agents like PROVOCHOLINE is highly competitive.
- Patent protections are generally not available for acetylcholine chloride, enabling multiple suppliers.
- Regulatory barriers are minimal, facilitating market entry for licensed manufacturers.
Summary
PROVOCHOLINE is supplied by a global network of manufacturers, primarily as generics, with major players based in the US, Switzerland, India, and Japan. Quality and regulatory compliance are key factors influencing distributor choice.
Key Takeaways
- Multiple global manufacturers produce PROVOCHOLINE, mainly as generics.
- The primary suppliers include Akorn, Sandoz, JGL, Hisamitsu, and Remedica.
- Market access depends on regulatory approval, formulation quality, and supply chain stability.
- The product is available for ophthalmic and diagnostic uses in regulated markets worldwide.
5 FAQs
1. Is PROVOCHOLINE still under patent protection?
No. Acetylcholine chloride is a generic compound with no active patents, allowing multiple manufacturers.
2. Are there regional differences in suppliers?
Yes. Major suppliers differ by region, with Indian, South Korean, Japanese, and US companies dominating their local markets.
3. What are the quality standards for suppliers?
Suppliers follow GMP standards, with certifications from regulatory agencies such as the FDA, EMA, or respective regional authorities.
4. How reliable is the supply chain for PROVOCHOLINE?
Supply chain stability depends on raw material availability, manufacturing capacity, and regulatory compliance. Disruptions are possible but generally manageable.
5. Can I source PROVOCHOLINE for research purposes from compounding labs?
Yes. Compounds are available through licensed compounding pharmacies, which typically source from authorized bulk manufacturers.
References
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Medicines Agency. (2023). List of Medicinal Products. Retrieved from https://www.ema.europa.eu/en/medicines/human/advanced-search
[3] Indian Pharmacopoeia Commission. (2021). Pharmacopoeia of India.
[4] Novartis. (2022). Sandoz Product Portfolio. Retrieved from https://www.sandoz.com/
[5] Hisamitsu Pharmaceutical. (2022). Company Overview. Retrieved from https://www.hisamitsu.co.jp/en/
